Article and Video CATEGORIES
In these videos from our 8th annual live patient forum, leading thoracic oncologists from around the world, as well as lung cancer patients who are active within the patient advocacy community, discussed subjects relevant to all targets as well as breakout sessions on rare mutations.
This 6-hour live virtual webinar was an opportunity for lung cancer patients and caregivers to hear from experts and participate in live virtual question and answer sessions. The forum offered panel discussions, live Q&A sessions, and breakout sessions focused on rare mutations such as EGFR, ALK, ROS, RET, and KRAS.
For videos from the full event, see https://cancergrace.org/video-collection/targeted-therapies-patient-forum-english
View these links for the complete AGENDA and FACULTY information.
We thank our sponsors for this year's support! #Novartis #Janssen #Blueprintmedicine #TakedaOncology #Astrazeneca #LillyOncology #genentech
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…